These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25697685)

  • 81. Diagnostic potential of baculovirus-expressed rubella virus envelope proteins.
    Seppänen H; Huhtala ML; Vaheri A; Summers MD; Oker-Blom C
    J Clin Microbiol; 1991 Sep; 29(9):1877-82. PubMed ID: 1774311
    [TBL] [Abstract][Full Text] [Related]  

  • 82. In situ removal of consensus dengue virus envelope protein domain III fused to hydrophobin in Pichia pastoris cultures.
    Cerezo J; Smith ME; Rodríguez Talou J
    Protein Expr Purif; 2019 Jan; 153():131-137. PubMed ID: 30240632
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Processing, secretion, and immunoreactivity of carboxy terminally truncated dengue-2 virus envelope proteins expressed in insect cells by recombinant baculoviruses.
    Deubel V; Bordier M; Megret F; Gentry MK; Schlesinger JJ; Girard M
    Virology; 1991 Jan; 180(1):442-7. PubMed ID: 1984665
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Casamino acids facilitate the secretion of recombinant dengue virus serotype-3 envelope domain III in Pichia pastoris.
    Kaushik N; Rohila D; Arora U; Raut R; Lamminmäki U; Khanna N; Batra G
    BMC Biotechnol; 2016 Feb; 16():12. PubMed ID: 26847361
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The production of recombinant dengue virus E protein using Escherichia coli and Pichia pastoris.
    Sugrue RJ; Cui T; Xu Q; Fu J; Chan YC
    J Virol Methods; 1997 Dec; 69(1-2):159-69. PubMed ID: 9504761
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Immunogenicity of a novel tetravalent dengue envelope protein domain III-based antigen in mice.
    Fahimi H; Sadeghizadeh M; Hassan ZM; Auerswald H; Schreiber M
    EXCLI J; 2018; 17():1054-1068. PubMed ID: 30564083
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Dengue-specific subviral nanoparticles: design, creation and characterization.
    Khetarpal N; Poddar A; Nemani SK; Dhar N; Patil A; Negi P; Perween A; Viswanathan R; Lünsdorf H; Tyagi P; Raut R; Arora U; Jain SK; Rinas U; Swaminathan S; Khanna N
    J Nanobiotechnology; 2013 May; 11():15. PubMed ID: 23706089
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A recombinant envelope protein from Dengue virus purified by IMAC is bioequivalent with its immune-affinity chromatography purified counterpart.
    Hermida L; Rodríguez R; Lazo L; López C; Márquez G; Páez R; Suárez C; Espinosa R; García J; Guzmán G; Guillén G
    J Biotechnol; 2002 Mar; 94(2):213-6. PubMed ID: 11796173
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Yellow fever virus envelope protein expressed in insect cells is capable of syncytium formation in lepidopteran cells and could be used for immunodetection of YFV in human sera.
    Barros MC; Galasso TG; Chaib AJ; Degallier N; Nagata T; Ribeiro BM
    Virol J; 2011 May; 8():261. PubMed ID: 21619598
    [TBL] [Abstract][Full Text] [Related]  

  • 90. M cell-targeting ligand and consensus dengue virus envelope protein domain III fusion protein production in transgenic rice calli.
    Kim TG; Kim MY; Huy NX; Kim SH; Yang MS
    Mol Biotechnol; 2013 Jul; 54(3):880-7. PubMed ID: 23250723
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cellufine sulfate column chromatography as a simple, rapid, and effective method to purify dengue virus.
    Kanlaya R; Thongboonkerd V
    J Virol Methods; 2016 Aug; 234():174-7. PubMed ID: 27155240
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Molecular characterization of recombinant premembrane protein of dengue virus serotype-2 for development of diagnostic assay.
    Munir R; Rafique S; Ali A; Amin I; Ahmed S; Vajeeha A; Shahid M; Samiullah TR; Idrees M; Tao YJ; Khan MU
    J Basic Microbiol; 2023 May; 63(5):489-498. PubMed ID: 36356225
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Optimization of Small-Scale Production of Zika Virus Envelope Glycoprotein by Transient Expression in HEK293 Cells for ELISA.
    Kim YC; Dumoux M; Owens RJ; Reyes-Sandoval A
    Methods Mol Biol; 2020; 2142():103-112. PubMed ID: 32367362
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins.
    Fibriansah G; Tan JL; Smith SA; de Alwis R; Ng TS; Kostyuchenko VA; Jadi RS; Kukkaro P; de Silva AM; Crowe JE; Lok SM
    Nat Commun; 2015 Feb; 6():6341. PubMed ID: 25698059
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Rapid diagnostic tests for dengue virus infection in febrile Cambodian children: diagnostic accuracy and incorporation into diagnostic algorithms.
    Carter MJ; Emary KR; Moore CE; Parry CM; Sona S; Putchhat H; Reaksmey S; Chanpheaktra N; Stoesser N; Dobson AD; Day NP; Kumar V; Blacksell SD
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003424. PubMed ID: 25710684
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Receptors and routes of dengue virus entry into the host cells.
    Cruz-Oliveira C; Freire JM; Conceição TM; Higa LM; Castanho MA; Da Poian AT
    FEMS Microbiol Rev; 2015 Mar; 39(2):155-70. PubMed ID: 25725010
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Correlation of serological markers and platelet count in the diagnosis of Dengue virus infection.
    Jyothi P; Metri BC
    Adv Biomed Res; 2015; 4():26. PubMed ID: 25709991
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A multiplex ELISA-based protein array for screening diagnostic antigens and diagnosis of Flaviviridae infection.
    Wang D; Zheng Y; Kang X; Zhang X; Hao H; Chen W; Liu L; Li X; Li L; Yuan Q; Chen F; Yang Y; Jiang Y; Jiang H
    Eur J Clin Microbiol Infect Dis; 2015 Jul; 34(7):1327-36. PubMed ID: 25796511
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Antibodies against immature virions are not a discriminating factor for dengue disease severity.
    Rodenhuis-Zybert IA; da Silva Voorham JM; Torres S; van de Pol D; Smit JM
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003564. PubMed ID: 25760350
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Novel vaccination approach for dengue infection based on recombinant immune complex universal platform.
    Kim MY; Reljic R; Kilbourne J; Ceballos-Olvera I; Yang MS; Reyes-del Valle J; Mason HS
    Vaccine; 2015 Apr; 33(15):1830-8. PubMed ID: 25728317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.